Tumor cells along with a small proportion of cancer stem cells exist in a stromal microenvironment consisting of vasculature, cancer-associated fibroblasts, immune cells and extracellular components.Recent epidemiolog...Tumor cells along with a small proportion of cancer stem cells exist in a stromal microenvironment consisting of vasculature, cancer-associated fibroblasts, immune cells and extracellular components.Recent epidemiological and clinical studies strongly support that vitamin D supplementation is associated with reduced cancer risk and favorable prognosis. Experimental results suggest that vitamin D not only suppresses cancer cells, but also regulates tumor microenvironment to facilitate tumor repression. In this review, we have outlined the current knowledge on epidemiological studies and clinical trials of vitamin D. Notably, wesummarized and discussed the anticancer action of vitamin D in cancer cells, cancer stem cells and stroma cells in tumor microenvironment, providing a better understanding of the role of vitamin D in cancer. We presently re-propose vitamin D to be a novel and economical anticancer agent.展开更多
Background Human adipose tissue-derived stromal cells （hADSCs） can be induced to differentiate along an osteoblastic lineage under stimulation of dexamethasone （DEX）. Recent studies, however, have questioned the e...Background Human adipose tissue-derived stromal cells （hADSCs） can be induced to differentiate along an osteoblastic lineage under stimulation of dexamethasone （DEX）. Recent studies, however, have questioned the efficacy of glucocorticoids such as DEX in mediating the osteogenesis process of skeletal progenitor cells and processed lipoaspirate cells. Is it possible to find a substitute for DEX？ Therefore, this study was designed to investigate osteogenic capacity and regulating mechanisms for osteoblastic differentiation of hADSCs by comparing osteogenic media （OM） containing either 1, 25-dihydroxyvitamin D3 （VD） or DEX and determine if VD was an ideal substitute for DEX as an induction agent for the osteogenesis of hADSCs. Methods Osteogenic differentiation of hADSCs was induced by osteogenic medium （OM） containing either 10 nmol/L VD or 100 nmol/L DEX. Differentiation of hADSCs into osteoblastic lineage was identified by alkaline phosphatase （ALP） staining, von Kossa staining, and reverse transcription-polymerase chain reaction assays for mRNA expression of osteogenesis-related genes such as type Ⅰ collagen （COL Ⅰ）, bone sialoprotein （BSP）, osteocalcin （OC）, bone morphogenetic protein （BMP）-2, BMP-4, BMP-6, BMP-7, runt-related transcription factor 2/core binding factor α1 （Runx2/Cbfal）, osterix （Osx）, and LIM mineralization protein- 1 （LMP- 1）. Results von Kossa staining revealed that the differentiated cells induced by both VD and DEX were mineralized in vitro. They also expressed osteoblast-related markers, such as ALP, COL Ⅰ, BSP, and OC. Runx2/Cbfal, Osx, BMP-6, and LMP-1 were upregulated during VD and DEX-induced hADSC osteoblastic differentiation, but BMP-4, BMP-7 were not. BMP-2 was only expressed in VD-induced differentiated cells. Conclusions VD or DEX-induced hADSCs differentiate toward the osteoblastic lineage in vitro. Runx2/Cbfal, Osx, BMP-2, BMP-6, and LMP-1 are involved in regulating osteoblastic differentiation of hADSCs, but BMP-4, BM展开更多
Vitamin D_3 has been found to produce therapeutic effects on obesity-associated insulin resistance and dyslipidemia through its potent anti-inflammatory activity, but the precise immunomodulatory mechanism remains poo...Vitamin D_3 has been found to produce therapeutic effects on obesity-associated insulin resistance and dyslipidemia through its potent anti-inflammatory activity, but the precise immunomodulatory mechanism remains poorly understood. In the present study we found that 1,25-dihydroxyvitamin D_3[1,25(OH)_2D_3], the biologically active form of vitamin D_3, significantly attenuated monosodium glutamate(MSG)-induced obesity and insulin resistance as indicated by body weight reduction, oral glucose tolerance improvement, and a glucose infusion rate increase as detected with hyperinsulinemiceuglycemic clamp. Moreover, 1,25(OH)_2D_3 not only restored pancreatic islet functions but also improved lipid metabolism in insulin-targeted tissues. The protective effects of 1,25(OH)_2D_3 on glycolipid metabolism were attributed to its ability to inhibit an obesity-activated inflammatory response in insulin secretory and targeted tissues, as indicated by reduced infiltration of macrophages in pancreas islets and adipose tissue while enhancing the expression of Tgf-β1 in liver tissue, which was accompanied byincreased infiltration of Treg cells in immune organs such as spleen and lymph node as well as in insulintargeted tissues such as liver, adipose, and muscle. Together, our findings suggest that 1,25(OH)_2D_3 serves as a beneficial immunomodulator for the prevention and treatment of obesity or metabolic syndrome through its anti-inflammatory effects.展开更多
目的 1α,25-二羟维生素D[1α,25(OH)2D3]是维生素D信号生物学功能的主要执行者,其血清水平不仅受其前体25-羟维生素D[25(OH)D]水平的调控,还受体内炎性状态的影响。本研究旨在分析慢性阻塞性肺疾病(COPD)患者中血清1α,25(OH)2D3水平...目的 1α,25-二羟维生素D[1α,25(OH)2D3]是维生素D信号生物学功能的主要执行者,其血清水平不仅受其前体25-羟维生素D[25(OH)D]水平的调控,还受体内炎性状态的影响。本研究旨在分析慢性阻塞性肺疾病(COPD)患者中血清1α,25(OH)2D3水平及其影响因素。方法收集124例COPD患者和188名健康对照者,采用酶联免疫吸附法检测血清1α,25(OH)2D3及25(OH)D水平,同期收集COPD患者血清C反应蛋白(CRP)、白细胞计数(WBC)、血红蛋白量(Hb)及白蛋白(Alb)等实验室资料。结果经两独立样本t检验,与对照组相比,COPD组中血清1α,25(OH)2D3和25(OH)D平均水平明显降低,分别为:28.33±5.87 vs 30.58±6.48pg/ml,t=3.108,P=0.002;25.73±5.44 vs 27.14±5.89ng/ml,t=2.128,P=0.034。根据患者病程分层分析,与稳定期COPD相比,急性加重期患者中血清1α,25(OH)2D3和25(OH)D平均水平亦显著降低,分别为:27.04±4.67 vs 29.17±5.01pg/ml,t=2.377,P=0.019;24.31±4.22 vs 26.66±4.56ng/ml,t=2.888,P=0.005。采用Spearman相关分析法检验COPD组中血清1α,25(OH)2D3水平的相关影响因素,纳入的变量包括血清25(OH)D水平及CRP、WBC、Hb、Alb等血清学指标。结果显示COPD组中血清1α,25(OH)2D3水平与25(OH)D和CRP呈正相关(r=0.291,P=0.002;r=0.352,P=0.004),与Alb呈负相关(r=-0.346,P=0.001),而与WBC和Hb无关(P>0.05)。结论 COPD患者中血清1α,25(OH)2D3水平与血清25(OH)D、CRP和Alb水平密切相关,并可能影响患者的病程。展开更多
维生素D作为一种重要的类固醇激素在骨骼发育和稳态维持中发挥重要作用。机体从外界获取的维生素D需在体内经过2次羟化转变为活性1,25-二羟基维生素D3,然后与维生素D受体(vitamin D receptor,VDR)结合后发挥生物学作用。传统观点认为1,...维生素D作为一种重要的类固醇激素在骨骼发育和稳态维持中发挥重要作用。机体从外界获取的维生素D需在体内经过2次羟化转变为活性1,25-二羟基维生素D3,然后与维生素D受体(vitamin D receptor,VDR)结合后发挥生物学作用。传统观点认为1,25-二羟基维生素D3在体内主要通过内分泌途径作用于肠道和肾脏,通过调节钙磷吸收和重吸收维持矿物质稳态,并因此间接调节骨骼稳态。近年发现1,25-二羟基维生素D3能直接作用于成骨细胞、破骨细胞和软骨细胞等,通过调节其增殖、分化直接调节骨形成与骨吸收,维持骨稳态的平衡。展开更多
The effect of La^(3+) on formation of osteoclast-like cells in rabbit bone marrow cells induced by 1,25-dihydroxyvitamin D_3 and their bone-resorbing activity was evaluated by counting the number of tartrate resistant...The effect of La^(3+) on formation of osteoclast-like cells in rabbit bone marrow cells induced by 1,25-dihydroxyvitamin D_3 and their bone-resorbing activity was evaluated by counting the number of tartrate resistant-acid phosphatase-positive [TRAP(+)] multi-nucleated cells and measuring the number and surface area of bone resorption pits with photomicrography and image analysis. The formation and morphological characteristics of osteoclast-like cells and bone resorption pits were observed under a phase contrast inverted microscope. La^(3+) promotes the formation of osteoclast-like cells at the concentration of 1.00×10^(-8)mol·L^(-1) compared with the control group(P<(0.01)), whereas no significant change in cell number is observed at higher concentrations(1.00×10^(-5), (1.00×)10^(-6) and 1.00×10^(-7) mol·L^(-1))(P>0.05). La^(3+) at the concentration of 1.00×10^(-8)mol·L^(-1) also increases the number and surface area of the resorption pits(P<0.01), but inhibits the bone-resorbing activity dose-dependently(P<0.01)at higher concentrations(1.00×10^(-5), 1.00×10^(-6) and 1.00×10^(-7) mol·L^(-1)). These findings suggest that La^(3+) may promote or inhibit the formation and bone-resorbing activity of osteoclast-like cells depending on its concentration.展开更多
The synthesis of 14-epi-19-nor-22-oxa-1α,25（OH）2D3 5 was started from diol 8 via Fall＇s method, oxidation, epimerization, protection, coupling with the 19-nor-A-ring 7, and then deprotection of the hydroxyl functi...The synthesis of 14-epi-19-nor-22-oxa-1α,25（OH）2D3 5 was started from diol 8 via Fall＇s method, oxidation, epimerization, protection, coupling with the 19-nor-A-ring 7, and then deprotection of the hydroxyl functions.展开更多
Our previous studies revealed that 1, 25-dihydroxyvrtamin D_3[1, 25 (OH)_2, D_3] and its two novel analogues (MC903 and EB1089) play an important role in the modulation of proliferation and differentiation of a newly ...Our previous studies revealed that 1, 25-dihydroxyvrtamin D_3[1, 25 (OH)_2, D_3] and its two novel analogues (MC903 and EB1089) play an important role in the modulation of proliferation and differentiation of a newly established human megakaryoblastic leu展开更多
Objective:Vitiligo is a chronic autoimmune depigmenting skin disorder.In this disease,the destruction of functional melanocytes can lead to reduced or absent pigmentation of the skin.Vitamin D deficiency has been repo...Objective:Vitiligo is a chronic autoimmune depigmenting skin disorder.In this disease,the destruction of functional melanocytes can lead to reduced or absent pigmentation of the skin.Vitamin D deficiency has been reported in some autoimmune diseases.The association of eosinophils and basophils with autoimmune diseases has also been recently examined.The present study was performed to evaluate the serum vitamin D concentration and blood eosinophil and basophil counts in patients with vitiligo.Methods:Data from 30 patients aged 20 to 40 years with vitiligo and 30 healthy people were collected.Blood samples were obtained to evaluate the serum vitamin D concentration,and eosinophil and basophil counts.The serum vitamin D concentration was measured by enzyme-linked immunosorbent assay.Independent t-test was used to compare the quantitative variables between the groups.Results:This descriptive cross-sectional study involved 30 patients with vitiligo.The average serum vitamin D concentration was significantly lower in the case group than in the control group(P=0.01).Furthermore,the mean serum vitamin D concentration was significantly lower in women than in men(P=0.03).The average eosinophil and basophil counts were not significantly different between the case and control groups.Discussion:The results of this study showed that the serum vitamin D concentration is low in patients with vitiligo.However,whether this reduction is a factor in the promotion of vitiligo or occurs after the onset of vitiligo remains unknown.Further studies on the serum vitamin D concentration in patients with vitiligo are needed to clarity this issue and develop effective treatments.展开更多
Objective To investigate the correlation between regulatory T （Treg） cells and postmenopausal osteoporosis and the antiosteoporotic effect of 1,25-dihydroxyvitamin D3 [1,25（OH）2D3] in relation to Treg cells. Metho...Objective To investigate the correlation between regulatory T （Treg） cells and postmenopausal osteoporosis and the antiosteoporotic effect of 1,25-dihydroxyvitamin D3 [1,25（OH）2D3] in relation to Treg cells. Methods Fifty female BALB/c mice were randomly divided into five groups： the basal control （BAS）, Sham, ovariectomy （OVX）, OVX＋diethylstilbestrol （OVX＋DES）, and OVX＋I,2S（OH）2D3. Tibias were harvested and processed with decalcification for quantitative bone histomorphometry. Femurs were stained by immunohistochemistry to detect Foxp3 protein expression. Spleens were used to detect Treg and Foxp3 gene expression by flow cy：ometry and quantitative RT-PCR, respectively. Results In comparison with the Sham group, a significant decrease was found in the OV~ group in such indices as trabecular bone volume/tc,tal tissue area （BV/TV）, trabecular number （Tb.N） and trabecular thickness （Tb.Th）. 1,25（OH）2D3 and DES partly prevented the decrease in BV/TV, Tb.N, Tb.Th in OVX mice. Treg cell number, Foxp3 mRI~：A expression in spleen and Foxp3 protein expression in femur significantly decreased in the OVX-tr^ated group compared with those in the sham group. 1,25（OH）2D3 and DES significantly increased Treg cell number and Foxp3 expression. Treg cells and Foxp3 gene expression were related to bone histomorphometric parameters. Conclusion The decrease in Treg cell numbers is relevant to the postmenopausal osteoporosis. The antiosteoporosis of 1,25（OH）2D3 is related to regulatory T cells.展开更多
目的建立一种竞争法定量检测人血清血浆中25-羟基维生素D[25-(OH)D]的免疫分析方法。方法本研究以磁颗粒-链酶亲和素-生物素为固相分离系统,样本中加入解离剂使维生素D结合蛋白(vitamin D binding protein,VDBP)变性而使25-(OH)D游离出...目的建立一种竞争法定量检测人血清血浆中25-羟基维生素D[25-(OH)D]的免疫分析方法。方法本研究以磁颗粒-链酶亲和素-生物素为固相分离系统,样本中加入解离剂使维生素D结合蛋白(vitamin D binding protein,VDBP)变性而使25-(OH)D游离出来,用生物素标记25-(OH)D,用吖碇酯标记一株抗-25-(OH)D的绵羊单抗,溯源到国际标准品,建立25-(OH)D定量免疫分析方法。结果此分析方法空白限不高于1.0 ng/mL;批内不精密度不超过5%,批间不精密度不超过10%;在线性范围为6~200 ng/mL;与金标准方法LC-MS/MS相比,相关性在0.97以上,偏差在±30%内,无系统偏差。结论该25-(OH)D化学发光定量检测方法,性能优异,适合临床推广使用。展开更多
基金supported by the National Natural Science Foundation of China(Nos.81770562,81602166 and 81703807)grants from the Science and Technology Planning Project of Luzhou,Sichuan Province,China(Nos.2016LZXNYD-Z04 and 2017LZXNYD-J02)
文摘Tumor cells along with a small proportion of cancer stem cells exist in a stromal microenvironment consisting of vasculature, cancer-associated fibroblasts, immune cells and extracellular components.Recent epidemiological and clinical studies strongly support that vitamin D supplementation is associated with reduced cancer risk and favorable prognosis. Experimental results suggest that vitamin D not only suppresses cancer cells, but also regulates tumor microenvironment to facilitate tumor repression. In this review, we have outlined the current knowledge on epidemiological studies and clinical trials of vitamin D. Notably, wesummarized and discussed the anticancer action of vitamin D in cancer cells, cancer stem cells and stroma cells in tumor microenvironment, providing a better understanding of the role of vitamin D in cancer. We presently re-propose vitamin D to be a novel and economical anticancer agent.
基金This study was supported by a grant from the National Natural Science Foundation of China (No. 30200319).
文摘Background Human adipose tissue-derived stromal cells （hADSCs） can be induced to differentiate along an osteoblastic lineage under stimulation of dexamethasone （DEX）. Recent studies, however, have questioned the efficacy of glucocorticoids such as DEX in mediating the osteogenesis process of skeletal progenitor cells and processed lipoaspirate cells. Is it possible to find a substitute for DEX？ Therefore, this study was designed to investigate osteogenic capacity and regulating mechanisms for osteoblastic differentiation of hADSCs by comparing osteogenic media （OM） containing either 1, 25-dihydroxyvitamin D3 （VD） or DEX and determine if VD was an ideal substitute for DEX as an induction agent for the osteogenesis of hADSCs. Methods Osteogenic differentiation of hADSCs was induced by osteogenic medium （OM） containing either 10 nmol/L VD or 100 nmol/L DEX. Differentiation of hADSCs into osteoblastic lineage was identified by alkaline phosphatase （ALP） staining, von Kossa staining, and reverse transcription-polymerase chain reaction assays for mRNA expression of osteogenesis-related genes such as type Ⅰ collagen （COL Ⅰ）, bone sialoprotein （BSP）, osteocalcin （OC）, bone morphogenetic protein （BMP）-2, BMP-4, BMP-6, BMP-7, runt-related transcription factor 2/core binding factor α1 （Runx2/Cbfal）, osterix （Osx）, and LIM mineralization protein- 1 （LMP- 1）. Results von Kossa staining revealed that the differentiated cells induced by both VD and DEX were mineralized in vitro. They also expressed osteoblast-related markers, such as ALP, COL Ⅰ, BSP, and OC. Runx2/Cbfal, Osx, BMP-6, and LMP-1 were upregulated during VD and DEX-induced hADSC osteoblastic differentiation, but BMP-4, BMP-7 were not. BMP-2 was only expressed in VD-induced differentiated cells. Conclusions VD or DEX-induced hADSCs differentiate toward the osteoblastic lineage in vitro. Runx2/Cbfal, Osx, BMP-2, BMP-6, and LMP-1 are involved in regulating osteoblastic differentiation of hADSCs, but BMP-4, BM
基金supported by grants from the National Natural Science Foundation of China (81773800 and 81471070)the CAMS Innovation Fund for Medical Sciences (CIFMS, 2016I2M-1-010 to Xiao-wei Zhang and 2016-I2M-1-012 to Wen Jin)
文摘Vitamin D_3 has been found to produce therapeutic effects on obesity-associated insulin resistance and dyslipidemia through its potent anti-inflammatory activity, but the precise immunomodulatory mechanism remains poorly understood. In the present study we found that 1,25-dihydroxyvitamin D_3[1,25(OH)_2D_3], the biologically active form of vitamin D_3, significantly attenuated monosodium glutamate(MSG)-induced obesity and insulin resistance as indicated by body weight reduction, oral glucose tolerance improvement, and a glucose infusion rate increase as detected with hyperinsulinemiceuglycemic clamp. Moreover, 1,25(OH)_2D_3 not only restored pancreatic islet functions but also improved lipid metabolism in insulin-targeted tissues. The protective effects of 1,25(OH)_2D_3 on glycolipid metabolism were attributed to its ability to inhibit an obesity-activated inflammatory response in insulin secretory and targeted tissues, as indicated by reduced infiltration of macrophages in pancreas islets and adipose tissue while enhancing the expression of Tgf-β1 in liver tissue, which was accompanied byincreased infiltration of Treg cells in immune organs such as spleen and lymph node as well as in insulintargeted tissues such as liver, adipose, and muscle. Together, our findings suggest that 1,25(OH)_2D_3 serves as a beneficial immunomodulator for the prevention and treatment of obesity or metabolic syndrome through its anti-inflammatory effects.
文摘目的 1α,25-二羟维生素D[1α,25(OH)2D3]是维生素D信号生物学功能的主要执行者,其血清水平不仅受其前体25-羟维生素D[25(OH)D]水平的调控,还受体内炎性状态的影响。本研究旨在分析慢性阻塞性肺疾病(COPD)患者中血清1α,25(OH)2D3水平及其影响因素。方法收集124例COPD患者和188名健康对照者,采用酶联免疫吸附法检测血清1α,25(OH)2D3及25(OH)D水平,同期收集COPD患者血清C反应蛋白(CRP)、白细胞计数(WBC)、血红蛋白量(Hb)及白蛋白(Alb)等实验室资料。结果经两独立样本t检验,与对照组相比,COPD组中血清1α,25(OH)2D3和25(OH)D平均水平明显降低,分别为:28.33±5.87 vs 30.58±6.48pg/ml,t=3.108,P=0.002;25.73±5.44 vs 27.14±5.89ng/ml,t=2.128,P=0.034。根据患者病程分层分析,与稳定期COPD相比,急性加重期患者中血清1α,25(OH)2D3和25(OH)D平均水平亦显著降低,分别为:27.04±4.67 vs 29.17±5.01pg/ml,t=2.377,P=0.019;24.31±4.22 vs 26.66±4.56ng/ml,t=2.888,P=0.005。采用Spearman相关分析法检验COPD组中血清1α,25(OH)2D3水平的相关影响因素,纳入的变量包括血清25(OH)D水平及CRP、WBC、Hb、Alb等血清学指标。结果显示COPD组中血清1α,25(OH)2D3水平与25(OH)D和CRP呈正相关(r=0.291,P=0.002;r=0.352,P=0.004),与Alb呈负相关(r=-0.346,P=0.001),而与WBC和Hb无关(P>0.05)。结论 COPD患者中血清1α,25(OH)2D3水平与血清25(OH)D、CRP和Alb水平密切相关,并可能影响患者的病程。
文摘维生素D作为一种重要的类固醇激素在骨骼发育和稳态维持中发挥重要作用。机体从外界获取的维生素D需在体内经过2次羟化转变为活性1,25-二羟基维生素D3,然后与维生素D受体(vitamin D receptor,VDR)结合后发挥生物学作用。传统观点认为1,25-二羟基维生素D3在体内主要通过内分泌途径作用于肠道和肾脏,通过调节钙磷吸收和重吸收维持矿物质稳态,并因此间接调节骨骼稳态。近年发现1,25-二羟基维生素D3能直接作用于成骨细胞、破骨细胞和软骨细胞等,通过调节其增殖、分化直接调节骨形成与骨吸收,维持骨稳态的平衡。
文摘The effect of La^(3+) on formation of osteoclast-like cells in rabbit bone marrow cells induced by 1,25-dihydroxyvitamin D_3 and their bone-resorbing activity was evaluated by counting the number of tartrate resistant-acid phosphatase-positive [TRAP(+)] multi-nucleated cells and measuring the number and surface area of bone resorption pits with photomicrography and image analysis. The formation and morphological characteristics of osteoclast-like cells and bone resorption pits were observed under a phase contrast inverted microscope. La^(3+) promotes the formation of osteoclast-like cells at the concentration of 1.00×10^(-8)mol·L^(-1) compared with the control group(P<(0.01)), whereas no significant change in cell number is observed at higher concentrations(1.00×10^(-5), (1.00×)10^(-6) and 1.00×10^(-7) mol·L^(-1))(P>0.05). La^(3+) at the concentration of 1.00×10^(-8)mol·L^(-1) also increases the number and surface area of the resorption pits(P<0.01), but inhibits the bone-resorbing activity dose-dependently(P<0.01)at higher concentrations(1.00×10^(-5), 1.00×10^(-6) and 1.00×10^(-7) mol·L^(-1)). These findings suggest that La^(3+) may promote or inhibit the formation and bone-resorbing activity of osteoclast-like cells depending on its concentration.
文摘The synthesis of 14-epi-19-nor-22-oxa-1α,25（OH）2D3 5 was started from diol 8 via Fall＇s method, oxidation, epimerization, protection, coupling with the 19-nor-A-ring 7, and then deprotection of the hydroxyl functions.
文摘Our previous studies revealed that 1, 25-dihydroxyvrtamin D_3[1, 25 (OH)_2, D_3] and its two novel analogues (MC903 and EB1089) play an important role in the modulation of proliferation and differentiation of a newly established human megakaryoblastic leu
文摘Objective:Vitiligo is a chronic autoimmune depigmenting skin disorder.In this disease,the destruction of functional melanocytes can lead to reduced or absent pigmentation of the skin.Vitamin D deficiency has been reported in some autoimmune diseases.The association of eosinophils and basophils with autoimmune diseases has also been recently examined.The present study was performed to evaluate the serum vitamin D concentration and blood eosinophil and basophil counts in patients with vitiligo.Methods:Data from 30 patients aged 20 to 40 years with vitiligo and 30 healthy people were collected.Blood samples were obtained to evaluate the serum vitamin D concentration,and eosinophil and basophil counts.The serum vitamin D concentration was measured by enzyme-linked immunosorbent assay.Independent t-test was used to compare the quantitative variables between the groups.Results:This descriptive cross-sectional study involved 30 patients with vitiligo.The average serum vitamin D concentration was significantly lower in the case group than in the control group(P=0.01).Furthermore,the mean serum vitamin D concentration was significantly lower in women than in men(P=0.03).The average eosinophil and basophil counts were not significantly different between the case and control groups.Discussion:The results of this study showed that the serum vitamin D concentration is low in patients with vitiligo.However,whether this reduction is a factor in the promotion of vitiligo or occurs after the onset of vitiligo remains unknown.Further studies on the serum vitamin D concentration in patients with vitiligo are needed to clarity this issue and develop effective treatments.
基金supported by Natural Science Foundation of Guangdong Province(10152402301000000)Science and Technology Planning Project of Dongguan(2011108102019)Science&Technology Innovation Fund of Guangdong Medical College(STIF201104)
文摘Objective To investigate the correlation between regulatory T （Treg） cells and postmenopausal osteoporosis and the antiosteoporotic effect of 1,25-dihydroxyvitamin D3 [1,25（OH）2D3] in relation to Treg cells. Methods Fifty female BALB/c mice were randomly divided into five groups： the basal control （BAS）, Sham, ovariectomy （OVX）, OVX＋diethylstilbestrol （OVX＋DES）, and OVX＋I,2S（OH）2D3. Tibias were harvested and processed with decalcification for quantitative bone histomorphometry. Femurs were stained by immunohistochemistry to detect Foxp3 protein expression. Spleens were used to detect Treg and Foxp3 gene expression by flow cy：ometry and quantitative RT-PCR, respectively. Results In comparison with the Sham group, a significant decrease was found in the OV~ group in such indices as trabecular bone volume/tc,tal tissue area （BV/TV）, trabecular number （Tb.N） and trabecular thickness （Tb.Th）. 1,25（OH）2D3 and DES partly prevented the decrease in BV/TV, Tb.N, Tb.Th in OVX mice. Treg cell number, Foxp3 mRI~：A expression in spleen and Foxp3 protein expression in femur significantly decreased in the OVX-tr^ated group compared with those in the sham group. 1,25（OH）2D3 and DES significantly increased Treg cell number and Foxp3 expression. Treg cells and Foxp3 gene expression were related to bone histomorphometric parameters. Conclusion The decrease in Treg cell numbers is relevant to the postmenopausal osteoporosis. The antiosteoporosis of 1,25（OH）2D3 is related to regulatory T cells.
